Reminder – Elekta’s Capital Markets Day in Stockholm on June 12, 2013

Tomas Puusepp, President and CEO, and other members of Elekta’s management team will give presentations focusing on Elekta’s strategy and development.

To attend, please register by e-mail to [email protected] no later than June 7, 2013.

It will also be possible to follow the Capital Markets Day over the phone and as a live webcast.

Live webcast:

http://elekta-livestreampublic.cmm.creo.se/capital-markets-day-2013

To take part over the phone, please dial in about 5-10 minutes in advance and use the access code: 973173#.

• Sweden: +46 8 506 443 86
• UK: +44 20 7153 9154
• US: +1 877 423 0830

We look forward to your participation on June 12.

Best regards,

Johan Andersson
Director Investor Relations                                    

For further information, please contact:
Elisabeth Natt och Dag, Information Manager, Elekta AB
+46 733 161 688, [email protected]

# # #

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.